ACC 2018 Resverlogix poster March 11, 2018

BIO-Europe Resverlogix presentation at 10:45 AM (Amsterdam time) March 14, 2018. Zenith presents the previous day

Next set of Resverlogix MD&A, Financials due around mid-March

Phase 2a Renal Trial anticipated start date March 15 according to the ClinicalTrials.gov page. However, last company presentation indicated first patient randomized Q2 2018.

First US patient randomized in BETonMACE Q1 2018 (by end of March) according to last company presentation

While there's no guarantee that anything earth shattering will happen in March, at least we have the above to look forward to. Plus, my favorite time of year is almost here with the NCAA tournament. March Madness! Despite the cloud of uncertainty surrounding my Arizona Wildcats, I'm still behind them 100% Bear Down Arizona! And go Resverlogix!